These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36043326)

  • 41. A multi-center, international, randomized, 2-year, parallel-group study to assess the superiority of IVUS-guided PCI versus qualitative angio-guided PCI in unprotected left main coronary artery (ULMCA) disease: Study protocol for OPTIMAL trial.
    De Maria GL; Testa L; de la Torre Hernandez JM; Terentes-Printzios D; Emfietzoglou M; Scarsini R; Bedogni F; Spitzer E; Banning A
    PLoS One; 2022; 17(1):e0260770. PubMed ID: 34995276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential Prognostic Effect Between First- and Second-Generation Drug-Eluting Stents in Coronary Bifurcation Lesions: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
    Lee JM; Hahn JY; Kang J; Park KW; Chun WJ; Rha SW; Yu CW; Jeong JO; Jeong MH; Yoon JH; Jang Y; Tahk SJ; Gwon HC; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1318-1331. PubMed ID: 26315734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
    Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
    Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.
    Stone GW; Christiansen EH; Ali ZA; Andreasen LN; Maehara A; Ahmad Y; Landmesser U; Holm NR
    Lancet; 2024 Mar; 403(10429):824-837. PubMed ID: 38401549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss.
    Lee SWL; Tam FCC; Lam SCC; Kong SL; Shea CP; Chan KKW; Wong MKL; Chan MPH; Wong AYT; Yung ASY; Lam YM; Zhang LW; Wu KKY; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2018 Apr; 11(4):e006034. PubMed ID: 29654119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES.
    Fujimura T; Matsumura M; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Ali ZA; Zhou Z; Mintz GS; Stone GW; Maehara A
    JACC Cardiovasc Interv; 2021 Aug; 14(15):1639-1650. PubMed ID: 34353595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, randomized, and multicenter DKCRUSH VIII trial.
    Ge Z; Kan J; Gao XF; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Sun ZQ; He PC; Wei L; Yang W; He YQ; Xue YZ; Wang LM; Miao LF; Pu J; Sun YW; Nie SP; Tao JH; Wen SY; Yang Q; Su X; Yao QC; Huang YJ; Xia Y; Shen FR; Qiu CG; Mao YL; Liu Q; Hu XQ; Du ZM; Nie RQ; Han YL; Zhang JJ; Chen SL
    Am Heart J; 2021 Apr; 234():101-110. PubMed ID: 33465369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention.
    Kwon W; Lee JM; Yun KH; Choi KH; Lee SJ; Lee JY; Lee SY; Kim SM; Cho JY; Kim CJ; Ahn HS; Nam CW; Yoon HJ; Park YH; Lee WS; Jeong JO; Song PS; Doh JH; Jo SH; Yoon CH; Kang MG; Koh JS; Lee KY; Lim YH; Cho YH; Cho JM; Jang WJ; Chun KJ; Hong D; Park TK; Yang JH; Choi SH; Gwon HC; Hahn JY; Song YB;
    Circ Cardiovasc Interv; 2023 Dec; 16(12):e013359. PubMed ID: 38018841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Impact of Intravascular Ultrasound-Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation: Randomized Study.
    Kim BK; Shin DH; Hong MK; Park HS; Rha SW; Mintz GS; Kim JS; Kim JS; Lee SJ; Kim HY; Hong BK; Kang WC; Choi JH; Jang Y;
    Circ Cardiovasc Interv; 2015 Jul; 8(7):e002592. PubMed ID: 26156151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcomes of double stent strategy for unprotected left main distal bifurcation lesions using current generation drug eluting stent comparing to early generation drug eluting stent; The Milan and New Tokyo (MITO) registry.
    Watanabe Y; Mitomo S; Naganuma T; Kawamoto H; Takagi K; Chieffo A; Carlino M; Montorfano M; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2021 Feb; 97(2):E198-E208. PubMed ID: 32384579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials.
    Bavishi C; Sardar P; Chatterjee S; Khan AR; Shah A; Ather S; Lemos PA; Moreno P; Stone GW
    Am Heart J; 2017 Mar; 185():26-34. PubMed ID: 28267472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
    Escaned J; Collet C; Ryan N; De Maria GL; Walsh S; Sabate M; Davies J; Lesiak M; Moreno R; Cruz-Gonzalez I; Hoole SP; Ej West N; Piek JJ; Zaman A; Fath-Ordoubadi F; Stables RH; Appleby C; van Mieghem N; van Geuns RJ; Uren N; Zueco J; Buszman P; Iñiguez A; Goicolea J; Hildick-Smith D; Ochala A; Dudek D; Hanratty C; Cavalcante R; Kappetein AP; Taggart DP; van Es GA; Morel MA; de Vries T; Onuma Y; Farooq V; Serruys PW; Banning AP
    Eur Heart J; 2017 Nov; 38(42):3124-3134. PubMed ID: 29020367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years.
    Buiten RA; Ploumen EH; Zocca P; Doggen CJM; Jessurun GAJ; Schotborgh CE; Roguin A; Danse PW; Benit E; Aminian A; van Houwelingen KG; Schramm AR; Stoel MG; Somi S; Hartmann M; Linssen GCM; von Birgelen C
    JACC Cardiovasc Interv; 2020 May; 13(9):1100-1109. PubMed ID: 32381186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial.
    Kirtane AJ; Yeung AC; Ball M; Carr J; O'Shaughnessy C; Mauri L; Liu M; Leon MB
    Catheter Cardiovasc Interv; 2020 May; 95(6):1067-1073. PubMed ID: 31301219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomised trials versus other limus-eluting stents and an adjusted indirect comparison.
    Cassese S; Ndrepepa G; King LA; Tada T; Fusaro M; Kastrati A
    Heart; 2012 Nov; 98(22):1632-40. PubMed ID: 22949487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries).
    Lee JM; Park KW; Han JK; Yang HM; Kang HJ; Koo BK; Bae JW; Woo SI; Park JS; Jin DK; Jeon DW; Oh SK; Park JS; Kim DI; Hyon MS; Jeon HK; Lim DS; Kim MG; Rha SW; Her SH; Hwang JY; Kim S; Choi YJ; Kang JH; Moon KW; Jang Y; Kim HS
    Am J Cardiol; 2014 Nov; 114(9):1329-38. PubMed ID: 25217457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial.
    Zhang J; Gao X; Kan J; Ge Z; Han L; Lu S; Tian N; Lin S; Lu Q; Wu X; Li Q; Liu Z; Chen Y; Qian X; Wang J; Chai D; Chen C; Li X; Gogas BD; Pan T; Shan S; Ye F; Chen SL
    J Am Coll Cardiol; 2018 Dec; 72(24):3126-3137. PubMed ID: 30261237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium.
    Erglis A; Narbute I; Sondore D; Jegere S; Kumsars I; Dombrovskis A; Grikis K; Briede I; Dombrovska K; Trusinskis K; Grave A; Erglis M; Kalejs M; Stradins P; Strazdins U
    J Interv Cardiol; 2022; 2022():7934868. PubMed ID: 36407753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study.
    Pavani M; Conrotto F; Cerrato E; D'Ascenzo F; Kawamoto H; Núñez-Gil IJ; Pennone M; Garbo R; Tomassini F; Colombo F; Scacciatella P; Varbella F; Chieffo A; Colombo A; Escaned J
    J Invasive Cardiol; 2018 Aug; 30(8):276-281. PubMed ID: 30068784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.